Chiral pharmaceuticals: Environment sources, potential human health impacts, remediation technologies and future perspective

Chiral pharmaceuticals (CPs), including non-steroid anti-inflammatory drugs (NSAIDs), β-blockers and some herbicide and pesticides, are widely used in aquaculture, clinical treatment and many other fields. However, people are increasingly concerned about such ubiquitous pollutants, which can frequen...

Full description

Bibliographic Details
Main Authors: Yaoyu Zhou, Shikang Wu, Hao Zhou, Hongli Huang, Jia Zhao, Yaocheng Deng, Hua Wang, Yuan Yang, Jian Yang, Lin Luo
Format: Article
Language:English
Published: Elsevier 2018-12-01
Series:Environment International
Online Access:http://www.sciencedirect.com/science/article/pii/S0160412018313709
id doaj-aed65adc6d9f4bec80aa0465f1df1848
record_format Article
spelling doaj-aed65adc6d9f4bec80aa0465f1df18482020-11-25T02:45:27ZengElsevierEnvironment International0160-41202018-12-01121523537Chiral pharmaceuticals: Environment sources, potential human health impacts, remediation technologies and future perspectiveYaoyu Zhou0Shikang Wu1Hao Zhou2Hongli Huang3Jia Zhao4Yaocheng Deng5Hua Wang6Yuan Yang7Jian Yang8Lin Luo9College of Resources and Environment, Hunan Agricultural University, Changsha 410128, China; Hunan International Scientific and Technological Cooperation Base of Agricultural Typical Pollution Remediation and Wetland Protection, Hunan Agricultural University, Changsha 410028, China; Corresponding authors at: College of Resources and Environment, Hunan Agricultural University, Changsha 410128, China.College of Resources and Environment, Hunan Agricultural University, Changsha 410128, China; Hunan International Scientific and Technological Cooperation Base of Agricultural Typical Pollution Remediation and Wetland Protection, Hunan Agricultural University, Changsha 410028, ChinaState Key Laboratory of Organic Geochemistry, Guangzhou Institute of Geochemistry, Chinese Academy of Sciences, Guangzhou 510640, China; University of Chinese Academy of Sciences, Beijing 100049, ChinaCollege of Resources and Environment, Hunan Agricultural University, Changsha 410128, ChinaCollege of Resources and Environment, Hunan Agricultural University, Changsha 410128, ChinaCollege of Resources and Environment, Hunan Agricultural University, Changsha 410128, China; Corresponding authors at: College of Resources and Environment, Hunan Agricultural University, Changsha 410128, China.College of Bioscience and Biotechnology, Hunan Agricultural University, Changsha 410128, ChinaCollege of Resources and Environment, Hunan Agricultural University, Changsha 410128, ChinaCollege of Resources and Environment, Hunan Agricultural University, Changsha 410128, ChinaCollege of Resources and Environment, Hunan Agricultural University, Changsha 410128, ChinaChiral pharmaceuticals (CPs), including non-steroid anti-inflammatory drugs (NSAIDs), β-blockers and some herbicide and pesticides, are widely used in aquaculture, clinical treatment and many other fields. However, people are increasingly concerned about such ubiquitous pollutants, which can frequently be detected in contaminated soil and water. In large part, the significant sources of chiral pharmaceuticals stem from industrial processes, such as the direct discharge of untreated or incompletely treated wastewaters containing chiral pharmaceuticals, incorrect storage and use, animal wastes and biosolids. The main ways for human exposure to chiral pharmaceuticals are the disease treatment process and chiral pharmaceuticals contaminants. According to the results of a series of toxic studies, some diseases, even cancers, may be associated with exposure to certain chiral pharmaceuticals. Therefore, the treatment of chiral pharmaceuticals has become an important issue. The current advanced remediation techniques for chiral pharmaceuticals include the conventional method (sorption and sonolysis), biotransformation (an aerobic granular sludge-sequencing batch reactor and constructed wetland system) and advanced oxidation processes (ozonation and photocatalysis). Herein, in this review, we summarize the current status and sources of chiral pharmaceuticals, potential effects on human health, as well as the superiority, disadvantages and prospects of current advanced remediation technologies. Moreover, we also anticipate the prospect of the future research needed for chiral pharmaceuticals pollutant remediation.http://www.sciencedirect.com/science/article/pii/S0160412018313709
collection DOAJ
language English
format Article
sources DOAJ
author Yaoyu Zhou
Shikang Wu
Hao Zhou
Hongli Huang
Jia Zhao
Yaocheng Deng
Hua Wang
Yuan Yang
Jian Yang
Lin Luo
spellingShingle Yaoyu Zhou
Shikang Wu
Hao Zhou
Hongli Huang
Jia Zhao
Yaocheng Deng
Hua Wang
Yuan Yang
Jian Yang
Lin Luo
Chiral pharmaceuticals: Environment sources, potential human health impacts, remediation technologies and future perspective
Environment International
author_facet Yaoyu Zhou
Shikang Wu
Hao Zhou
Hongli Huang
Jia Zhao
Yaocheng Deng
Hua Wang
Yuan Yang
Jian Yang
Lin Luo
author_sort Yaoyu Zhou
title Chiral pharmaceuticals: Environment sources, potential human health impacts, remediation technologies and future perspective
title_short Chiral pharmaceuticals: Environment sources, potential human health impacts, remediation technologies and future perspective
title_full Chiral pharmaceuticals: Environment sources, potential human health impacts, remediation technologies and future perspective
title_fullStr Chiral pharmaceuticals: Environment sources, potential human health impacts, remediation technologies and future perspective
title_full_unstemmed Chiral pharmaceuticals: Environment sources, potential human health impacts, remediation technologies and future perspective
title_sort chiral pharmaceuticals: environment sources, potential human health impacts, remediation technologies and future perspective
publisher Elsevier
series Environment International
issn 0160-4120
publishDate 2018-12-01
description Chiral pharmaceuticals (CPs), including non-steroid anti-inflammatory drugs (NSAIDs), β-blockers and some herbicide and pesticides, are widely used in aquaculture, clinical treatment and many other fields. However, people are increasingly concerned about such ubiquitous pollutants, which can frequently be detected in contaminated soil and water. In large part, the significant sources of chiral pharmaceuticals stem from industrial processes, such as the direct discharge of untreated or incompletely treated wastewaters containing chiral pharmaceuticals, incorrect storage and use, animal wastes and biosolids. The main ways for human exposure to chiral pharmaceuticals are the disease treatment process and chiral pharmaceuticals contaminants. According to the results of a series of toxic studies, some diseases, even cancers, may be associated with exposure to certain chiral pharmaceuticals. Therefore, the treatment of chiral pharmaceuticals has become an important issue. The current advanced remediation techniques for chiral pharmaceuticals include the conventional method (sorption and sonolysis), biotransformation (an aerobic granular sludge-sequencing batch reactor and constructed wetland system) and advanced oxidation processes (ozonation and photocatalysis). Herein, in this review, we summarize the current status and sources of chiral pharmaceuticals, potential effects on human health, as well as the superiority, disadvantages and prospects of current advanced remediation technologies. Moreover, we also anticipate the prospect of the future research needed for chiral pharmaceuticals pollutant remediation.
url http://www.sciencedirect.com/science/article/pii/S0160412018313709
work_keys_str_mv AT yaoyuzhou chiralpharmaceuticalsenvironmentsourcespotentialhumanhealthimpactsremediationtechnologiesandfutureperspective
AT shikangwu chiralpharmaceuticalsenvironmentsourcespotentialhumanhealthimpactsremediationtechnologiesandfutureperspective
AT haozhou chiralpharmaceuticalsenvironmentsourcespotentialhumanhealthimpactsremediationtechnologiesandfutureperspective
AT honglihuang chiralpharmaceuticalsenvironmentsourcespotentialhumanhealthimpactsremediationtechnologiesandfutureperspective
AT jiazhao chiralpharmaceuticalsenvironmentsourcespotentialhumanhealthimpactsremediationtechnologiesandfutureperspective
AT yaochengdeng chiralpharmaceuticalsenvironmentsourcespotentialhumanhealthimpactsremediationtechnologiesandfutureperspective
AT huawang chiralpharmaceuticalsenvironmentsourcespotentialhumanhealthimpactsremediationtechnologiesandfutureperspective
AT yuanyang chiralpharmaceuticalsenvironmentsourcespotentialhumanhealthimpactsremediationtechnologiesandfutureperspective
AT jianyang chiralpharmaceuticalsenvironmentsourcespotentialhumanhealthimpactsremediationtechnologiesandfutureperspective
AT linluo chiralpharmaceuticalsenvironmentsourcespotentialhumanhealthimpactsremediationtechnologiesandfutureperspective
_version_ 1724762698079535104